-Reuters
Organon Expects Lower EBITDA Margin For FY22, Clocks Mixed Q2 Earnings
Organon & Co’s (NYSE:OGN) Q2 sales decreased 1% Y/Y to $1.59 billion, beating the consensus of $1.54 billion. The sales…
Related Posts
Carrier Global’s Debt Overview
Shares of Carrier Global (NYSE:CARR) moved lower by 0.71% in the past three months. Before we understand the importance of debt, let us look at how much debt Carrier Global has.
Synthetic Biotechnology Company Amyris Reveals Progress In Ingredients Supply Transaction
Amyris Inc (NASDAQ:AMRS), a synthetic biotechnology company, has completed the negotiation of key financial and business terms for the…